ClinicalTrials.gg
CompletedNCT06110247Updated Jul 30, 2024

Evaluation of Renal Oxygenation by NIRS in Pediatric Endourologic Stone Surgery

An observational study in Renal Stone, Kidney; Complications and Ureter Stone, sponsored by Ankara City Hospital Bilkent. Completed at 1 site in Turkey (Türkiye). Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2024-07-30.

Sponsored by Ankara City Hospital Bilkent · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
136
Ages
1 Year to 18 Years
Sex
All
01

Study summary

The study aims to compare renal oxygenation levels in retrograde intrarenal surgery (RIRS) and ureteroscopy (URS) procedures with a control group. Additionally, it seeks to determine if there is a connection between postoperative infection parameters and intraoperative renal oxygenation measurements.

Read the detailed description

The study will involve ASA class I-III pediatric patients aged 1-18 undergoing RIRS, URS, and hypospadias surgery under general anesthesia. Patients will be divided into three groups: Group R (RIRS), Group U (URS), and Group H (Hypospadias/Control). Data collection will include patient height and weight. In Groups R and U, pre- and postoperative measurements such as hemoglobin, hematocrit, leukocyte count, BUN, serum creatinine, procalcitonin, interleukin-6, and CRP values will be recorded.

All three groups will undergo NIRS monitoring alongside routine ASA monitoring. Renal NIRS probes will be positioned using ultrasonography, and the average of three measurements will determine the regional oxygen saturation index (rSO2) as the initial value. NIRS, pulse oximetry, and hemodynamic data will be recorded every 5 minutes until recovery from anesthesia just prior to induction. A decrease of 20% or more than 20% when comparing NIRS values during follow-up with the baseline will be considered significant. The study will also document anesthesia and surgery times, as well as postoperative fever and the amount of irrigation fluid used in Groups R and U.

02

Conditions studied

  • Renal Stone
  • Kidney; Complications
  • Ureter Stone
  • Renal Oxygenation

Keywords

  • Near infrared spectroscopy
  • Pediatric
  • Renal oxygenation
  • Endourologic stone surgery
  • infectious complication
03

In context

Nephrolithiasis

467 studies on the registry are indexed under Nephrolithiasis; 108 are open to participants now.

This study's enrollment of 136 is above the median of 96 across 84 observational studies indexed under Nephrolithiasis.

Browse Nephrolithiasis studies →

Lead sponsor

Ankara City Hospital Bilkent is the lead sponsor of 437 studies on the registry; 109 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

ASA I-III class between the ages of 1-18, patients who will undergo RIRS and URS surgery under standard general anesthesia, as well as patients who will undergo hypospadias surgery (without a history of stones or kidney problems).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1-18 years ASA I-III class,
  • Patients who will undergo RIRS, URS and Hypospadias surgeries under standard general anesthesia.
  • Patients whose informed consent form is approved by their parents will be included in the study.

Exclusion criteria

Exclusion Criteria:

  • Exclusio criteria were the history of renal failure, renal tumors, infection of the perirenal region; receiving colloid or blood transfusion, having abscess, body mass index (BMI) not in the normal limits (≤3% or ≥97%)
  • Patients whose parents do not approve the informed consent form will not be included in the study.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
136 participants (actual)
Target follow-up
2 Days
Patient registry
Yes

Groups and cohorts

  • Group R

    Pre- and Postoperative hemoglobin (Hb), hematocrit (Htc), leukocyte (WBC), blood urea nitrogen (BUN), serum creatinine (sCr), procalcitonin, interleukin-6 and CRP values will be recorded. NIRS monitoring will be performed in addition to routine ASA monitoring. After the positions of the renal NIRS probes are confirmed by ultrasonography, the average value of the three measurements will be taken and the regional oxygen saturation index (rSO2) will be accepted as the initial value. NIRS, pulse oximetry, and hemodynamic data will be recorded every 5 minutes until recovery from anesthesia just prior to induction. When comparing the NIRS values measured during follow-up with the baseline NIRS value, a decrease of 20% or more than 20% will be considered significant. Anesthesia and surgery times will also be recorded. Postoperative fever and the amount of irrigation fluid used during the surgical procedure will be recorded .

    Device: NIRS · Other: Taking a blood sample

  • Group U

    Pre- and Postoperative hemoglobin (Hb), hematocrit (Htc), leukocyte (WBC), blood urea nitrogen (BUN), serum creatinine (sCr), procalcitonin, interleukin-6 and CRP values will be recorded. NIRS monitoring will be performed in addition to routine ASA monitoring. After the positions of the renal NIRS probes are confirmed by ultrasonography, the average value of the three measurements will be taken and the regional oxygen saturation index (rSO2) will be accepted as the initial value. NIRS, pulse oximetry, and hemodynamic data will be recorded every 5 minutes until recovery from anesthesia just prior to induction. When comparing the NIRS values measured during follow-up with the baseline NIRS value, a decrease of 20% or more than 20% will be considered significant. Anesthesia and surgery times will also be recorded. Postoperative fever and the amount of irrigation fluid used during the surgical procedure will be recorded .

    Device: NIRS · Other: Taking a blood sample

  • Group H

    The study involves continuous NIRS monitoring in addition to routine ASA monitoring. To establish the initial value of regional oxygen saturation (rSO2), renal NIRS probes will be positioned using ultrasonography, and an average of three measurements will be taken. Throughout the procedure, NIRS data, along with pulse oximetry and hemodynamic data, will be recorded at 5-minute intervals until the patient recovers from anesthesia just prior to induction. Significant changes in NIRS values will be determined if a decrease of 20% or more compared to the baseline measurement is observed. Anesthesia and surgery times will also be recorded.

    Device: NIRS

Interventions

  • DeviceNIRS

    After the positions of the renal NIRS probes are confirmed by ultrasonography, the average value of the three measurements will be taken and the regional oxygen saturation index (rSO2) will be accepted as the initial value.

  • OtherTaking a blood sample

    Pre- and Postoperative hemoglobin (Hb), hematocrit (Htc), leukocyte (WBC), blood urea nitrogen (BUN), serum creatinine (sCr), procalcitonin, interleukin-6 and CRP values will be recorded.

06

What researchers measure

Primary outcomes

  1. Near infrared spectroscopy (NIRS)

    Rretrograde intrarenal surgery (RIRS), ureteroscopy (URS) and hypospadias operations, renal oxygen level will be measured via NIRS monitor.

    Time frame: NIRS values will be documented immediately prior to induction and every 5 minutes until recovery from anesthesia.

Secondary outcomes

  1. Infection parameters

    Procalcitonin

    Time frame: Preoperative and postoperative 24th hour

  2. Infection parameters

    Interleukin-6

    Time frame: Preoperative and postoperative 24th hour

  3. Infection parameters

    C-reactive protein (CRP)

    Time frame: Preoperative and postoperative 24th hour

07

Study locations

1 site
  • Ankara Bilkent City Hospital,Department Of Anesthesiology and Reanimation
    Ankara, Çankaya 06800, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06110247
Responsible party
Şengül Özmert (Assoc. Prof. MD, Ankara City Hospital Bilkent) — Principal investigator
First posted
Oct 31, 2023
Start date
Nov 3, 2023
Primary completion
Mar 7, 2024
Completion
Apr 30, 2024
Last update
Jul 30, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion